Study guide

15.1 Federal Confidentiality Laws: 42 CFR Part 2 Foundations

IC&RC Advanced Alcohol & Drug Counselor AADC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Master's-Level Credentialing

1.1 IC&RC AADC Exam Purpose, Structure & Scoring 1.2 Master's-Level Preparation Strategy & Exam Blueprint Navigation

2 Chapter 2: Diagnostic Systems & DSM-5-TR Substance Use Disorders

2.1 DSM-5-TR Diagnostic Criteria & Severity Continuum 2.2 Substance Classes, Intoxication & Withdrawal Syndromes 2.3 Neurobiology of Addiction & Tolerance Mechanics

3 Chapter 3: Standardized Screening, Comprehensive Assessment & Diagnostic Feedback

3.1 Clinical Distinctions Between Screening and Assessment 3.2 Evidence-Based Assessment Instruments 3.3 Selecting Culturally Appropriate Screening and Assessment Tools 3.4 Biopsychosocial Intake Interviewing & Stage-of-Change Assessment 3.5 Documenting Screening and Assessment Results 3.6 Discussing Diagnostic Results and Recommendations

4 Chapter 4: Complex Co-Occurring Psychiatric Disorders & Differential Diagnosis

4.1 Differential Diagnosis Principles: Primary vs Substance-Induced Disorders 4.2 Co-Occurring Depressive, Bipolar & Anxiety Disorders 4.3 Personality Disorders, PTSD & Severe Mental Illness

5 Chapter 5: Trauma, Suicide Risk & Crisis Engagement

5.1 Trauma Assessment & Complex Post-Traumatic Stress 5.2 Lethality & Suicide Risk Formulation 5.3 Crisis Intervention & Motivational Engagement

6 Chapter 6: ASAM Criteria & Multidimensional Level of Care Placement

6.1 ASAM Six Assessment Dimensions 6.2 ASAM Continuum of Care Levels 6.3 Level-of-Care Transitions, Continued Stay & Discharge

7 Chapter 7: Treatment Planning & SMART Goal Formulation

7.1 Problem Identification & Clinical Formulation 7.2 SMART Goals, Objectives & Interventions 7.3 Treatment Plan Evolution, Ongoing Review & Documentation 7.4 Educating the Person Served About the Counseling Process

8 Chapter 8: Pharmacotherapy & Medications for Substance Use Disorders

8.1 Medications for Opioid Use Disorder (MOUD) 8.2 Medications for Alcohol and Tobacco Use Disorders 8.3 Psychiatric Pharmacotherapy & The Counselor's Role

9 Chapter 9: Interprofessional Collaboration, Care Coordination & Referral

9.1 Multidisciplinary Teamwork & Integrated Healthcare 9.2 Referral Processes & Continuity of Care 9.3 Coordination with Specialized Systems

10 Chapter 10: Cognitive Behavioral Therapy & Relapse Prevention

10.1 Theoretical Foundations of CBT in Addiction 10.2 Cognitive Restructuring & Behavioral Coping Skills 10.3 Relapse Prevention Models & The Abstinence Violation Effect 10.4 Community Reinforcement & Third-Wave CBT Approaches

11 Chapter 11: Motivational Interviewing & Motivational Enhancement Therapy

11.1 Spirit & Foundational Principles of Motivational Interviewing 11.2 Four Processes & OARS Core Clinical Skills 11.3 Motivational Enhancement Therapy Protocol & Change Talk

12 Chapter 12: Contingency Management, Twelve-Step Facilitation & Third-Wave Behavioral Approaches

12.1 Operant Conditioning & Contingency Management Protocols 12.2 Twelve-Step Facilitation (TSF) Therapy 12.3 Mindfulness-Based Relapse Prevention (MBRP) & Acceptance Approaches 12.4 Multiple Pathways of Recovery & Adapting Intervention Strategies

13 Chapter 13: Family Systems, Adolescent Considerations & Group Psychotherapy

13.1 Family Systems Approaches in Addiction Treatment 13.2 Adolescent-Specific Assessment & Evidence-Based Interventions 13.3 Group Psychotherapy Dynamics & Facilitation

14 Chapter 14: Psychoeducation, Health Promotion & Infectious Disease

14.1 Medical & Health Consequences of Chronic Substance Use 14.2 Infectious Diseases: HIV/AIDS, Viral Hepatitis & STI Transmission 14.3 Wellness, Lifestyle Modification & Holistic Recovery Support

15 Chapter 15: Confidentiality, 42 CFR Part 2 & Legal Mandates

15.1 Federal Confidentiality Laws: 42 CFR Part 2 Foundations 15.2 Comparing 42 CFR Part 2 and HIPAA: Consent & Disclosures 15.3 Medical Emergencies, Child/Elder Abuse & Mandated Reporting 15.4 Duty to Warn (Tarasoff) & Responding to Subpoenas and Court Orders

16 Chapter 16: Clinical Supervision Models, Competency Evaluation & Gatekeeping

16.1 Theoretical Frameworks & Models of Clinical Supervision 16.2 The Supervisory Relationship, Roles & Modalities 16.3 Competency Evaluation, Formative Feedback & Gatekeeping 16.4 Vicarious Liability, Legal Risks & Managing Impaired Counselors

17 Chapter 17: Professional Ethics, Boundaries & Multicultural Competence

17.1 Professional Codes of Ethics & Ethical Decision-Making Frameworks 17.2 Dual Relationships, Professional Boundaries & Conflict of Interest 17.3 Multicultural Competence, Cultural Humility & Health Disparities 17.4 Technology, Telehealth & Digital Ethics in Addiction Counseling 17.5 Integrating Research Into Clinical Practice

15.1 Federal Confidentiality Laws: 42 CFR Part 2 Foundations

Key Takeaways Explain This Topic AI

42 CFR Part 2 was enacted under the Drug Abuse Office and Treatment Act of 1972 and codified in the Public Health Service Act (42 U.S.C. § 290dd-2) to establish a protective legal shield preventing criminalization and discrimination against individuals seeking substance use disorder (SUD) treatment.

Part 2 applies exclusively when a strict two-pronged threshold is satisfied: the healthcare entity must be (1) federally assisted and (2) meet the regulatory definition of a specialized 'Program' under § 2.11 that holds itself out as providing SUD diagnosis, treatment, or referral.

General healthcare facilities—such as hospital emergency departments, trauma centers, urgent care clinics, and primary care medical practices—are not Part 2 programs, even when treating acute overdoses or prescribing buprenorphine, unless they maintain a distinct, identified addiction treatment unit.

Patient identifying information is defined broadly under § 2.11 as any information that identifies or could reasonably be used to identify an individual, directly or indirectly, as having or having had an SUD, or as being a patient in a specialized Part 2 facility.

Under minor consent regulations (§ 2.14), where state law authorizes a minor to consent to their own SUD treatment without parental authorization, the minor alone holds legal authority over disclosures, strictly barring communication with parents without the minor's written consent.

Last updated: September 2026

15.1 Federal Confidentiality Laws: 42 CFR Part 2 Foundations

Note

The Public Health Shield of Addiction Confidentiality : Confidentiality in substance use disorder treatment is not merely an administrative courtesy or professional preference; it is a foundational public health imperative. Historically, individuals suffering from addictive disorders faced severe social ostracism, civil discrimination, and criminal prosecution if their treatment status became known. Congress recognized that without uncompromising, statutory confidentiality protections, individuals with substance use disorders would actively avoid life-saving medical care out of legitimate fear that their medical records would be weaponized against them in criminal proceedings, child custody disputes, or employment terminations.

Legislative Origins & Statutory Authority (42 U.S.C. § 290dd-2)

The federal statutory framework governing the confidentiality of substance use disorder (SUD) records originated during a critical juncture in American drug policy during the early 1970s. As the federal government escalated law enforcement interventions against illicit drug distribution, public health authorities recognized that the intrusion of criminal justice surveillance into therapeutic environments would collapse voluntary treatment admissions.

To establish an unbreachable wall of separation between healthcare and criminal justice surveillance, Congress enacted two landmark statutes:

The Drug Abuse Office and Treatment Act of 1972 (Public Law 92-255) , which established comprehensive privacy protections for drug abuse patient records.

The Comprehensive Alcohol Abuse and Alcoholism Prevention, Treatment, and Rehabilitation Act Amendments of 1974 (Public Law 93-282) , which extended identical federal protections to alcohol use disorder records.

These enactments were consolidated and codified within the Public Health Service Act at 42 U.S.C. § 290dd-2 . The administrative regulations implementing this statute were promulgated by the Department of Health and Human Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) as Title 42 of the Code of Federal Regulations, Part 2 (42 CFR Part 2) , formally titled "Confidentiality of Substance Use Disorder Patient Records."

The express legislative and regulatory intent of Part 2 is to ensure that a patient receiving treatment for an SUD in a federally assisted program is not made more vulnerable to criminal charges, loss of employment, loss of housing, or loss of child custody than an individual who chooses not to seek treatment.

The Two-Pronged Applicability Threshold

A primary task for the advanced addiction counselor and clinical supervisor is determining precisely when 42 CFR Part 2 applies to a clinical service or healthcare organization. Part 2 does not apply universally to all medical providers, nor does it attach to every medical chart that mentions alcohol or drug consumption. Instead, Part 2 jurisdiction is triggered only when a strict, two-pronged threshold is satisfied: the entity must be federally assisted and must qualify as a specialized program . +-----------------------------------------------------------------------------------+

  • | THE TWO-PRONGED PART 2 APPLICABILITY THRESHOLD |
  • +-----------------------------------------------------------------------------------+
  • | PRONG 1: FEDERALLY ASSISTED |
  • | Must satisfy at least ONE of the following federal nexuses: |
  • | * Direct federal grant, contract, or cooperative agreement funding (SAMHSA) |
  • | * Participation in Medicare or Medicaid (even a single reimbursed claim) |
  • | * Federal tax-exempt status under Internal Revenue Code § 501(c)(3) |
  • | * Authorization to conduct business by the federal government (e.g., DEA |
  • | registration to dispense Schedule II-V controlled substances for SUD) |
  • | * Direct operation by the federal government (VA, DoD, IHS, Federal BOP) |
  • +-----------------------------------------------------------------------------------+
  • AND
  • +-----------------------------------------------------------------------------------+
  • | PRONG 2: QUALIFIES AS A "PROGRAM" (§ 2.11) |
  • | Must satisfy at least ONE of the following structural definitions: |
  • | * An individual provider whose PRIMARY FUNCTION is the provision of SUD |
  • | diagnosis, treatment, or referral for treatment |
  • | * An identified medical unit or specialty department within a general medical |
  • | facility that HOLDS ITSELF OUT as providing SUD diagnosis, treatment, or |
  • | referral for treatment (e.g., hospital chemical dependency rehabilitation) |
  • | * Medical personnel or specialized staff within a general medical facility |
  • | whose PRIMARY FUNCTION is the provision of SUD services and who are |
  • | identified as such (e.g., specialized addiction consult-liaison team) |
  • +-----------------------------------------------------------------------------------+
  • Clinical Distinction: General Healthcare vs. Specialized Programs

Under 42 CFR § 2.11, the definition of a "program" requires an entity to "hold itself out" as providing substance use disorder diagnosis, treatment, or referral. An entity holds itself out through state licensing as an addiction facility, public advertising, community directory listings, website services, or explicit organizational mission statements.

Crucially, general medical facilities—such as hospital emergency departments, urgent care clinics, trauma centers, and primary care medical practices—are NOT Part 2 programs , even if they routinely treat acute drug overdoses, manage acute alcohol withdrawal, order toxicology screens, or prescribe medications for opioid use disorder (MOUD). Records generated in a general emergency department or primary care clinic are governed by the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule rather than Part 2, unless the hospital maintains a designated, distinct specialty addiction unit or consult service that generates the record.

Setting Characteristic General Medical Setting (HIPAA Only) Specialized SUD Program (42 CFR Part 2)

Primary Function Comprehensive acute or ambulatory healthcare across diverse medical conditions. Primary function is dedicated SUD diagnosis, treatment, or referral.

Community Representation Holds itself out as a general hospital, emergency room, or family practice clinic. Holds itself out publicly or via state licensure as an addiction specialty provider.

Addiction Pharmacotherapy Primary care physician prescribes buprenorphine as part of general family medicine. Opioid Treatment Program (OTP) or specialized addiction clinic dispenses methadone/buprenorphine.

Emergency Toxicology Hospital ED orders toxicology panel during trauma or acute overdose resuscitation. Residential or outpatient addiction facility administers routine monitoring drug screens.

Governing Regulation HIPAA Privacy Rule (45 CFR Parts 160/164). 42 CFR Part 2 AND HIPAA Privacy Rule (more stringent rule governs).

Defining Patient Identifying Information (§ 2.11)

Under 42 CFR § 2.11, Patient Identifying Information is defined as any information that identifies or could reasonably be used to identify an individual—either directly or indirectly—as having or having had a substance use disorder, or as being or having been diagnosed, treated, or referred for treatment for a substance use disorder by a Part 2 program.

Patient identifying information encompasses:

Direct Identifiers : Full name, address, Social Security number, date of birth, biometric records, photographs, and electronic contact data.

Indirect Identifiers : Detail regarding treatment enrollment, appointment schedules, room numbers, diagnostic codes (ICD-10 or DSM-5-TR), clinical progress notes, toxicology screen logs, medication administration records, or billing records that link the individual to an addiction treatment encounter.

The Mere Fact of Enrollment : In a specialized chemical dependency facility, the mere acknowledgment that an individual is or ever was a patient constitutes an unauthorized disclosure of patient identifying information, because that acknowledgment confirms the individual has or had an SUD.

Minor Consent Principles in Addiction Care (§ 2.14)

A critical legal domain tested on the IC&RC AADC examination involves the management of minor confidentiality. Under 42 CFR § 2.14, the intersection between state minor consent laws and federal confidentiality creates a strict, mandatory rule:

Important

The Minor's Sole Authority Rule (§ 2.14) : Where state law authorizes a minor to consent to their own substance use disorder treatment without parental consent, the minor alone holds the legal authority to execute a Part 2 consent form . In such jurisdictions, the counselor and treatment program are legally forbidden from disclosing treatment records, progress reports, attendance logs, or toxicology results—or even confirming enrollment—to the minor's parents or legal guardians without the minor's explicit written consent.

This rule applies regardless of whether the parents are paying for treatment out-of-pocket, carry the minor on their commercial health insurance, or initiated the initial clinical contact. If state law does not permit minor consent (requiring parental consent for SUD treatment), both the minor and the parent or guardian must sign the Part 2 consent form to authorize disclosure.

Regulatory Enforcement & Modern Penalty Architecture

Historically, violations of 42 CFR Part 2 were enforced through criminal misdemeanor fines of not more than $500 for a first offense and not more than $5,000 for each subsequent offense, investigated by the United States Attorney's Office. Because criminal prosecutions for privacy breaches were exceedingly rare, compliance was historically uneven.

To establish robust regulatory enforcement, Congress enacted Section 3221 of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 , which amended 42 U.S.C. § 290dd-2 and aligned Part 2 penalties with the civil enforcement framework of HIPAA:

HIPAA Civil Monetary Penalties : Part 2 violations are now subject to the tiered civil monetary penalties established under Section 1176 of the Social Security Act (codified at 45 CFR Part 160), enforced directly by the HHS Office for Civil Rights (OCR).

Tiered Penalty Ranges : Penalties range from $100 to over $50,000 per violation depending on the level of culpability (ranging from lack of knowledge to willful neglect), with annual statutory maximum caps exceeding $2,000,000.

Anti-Discrimination Protections : CARES Act Section 3221 explicitly prohibits the use of Part 2 records in any criminal, civil, administrative, or legislative proceeding against a patient, and bars the use of records to discriminate against patients in employment, housing, credit, healthcare access, or government benefits.